125 related articles for article (PubMed ID: 11432668)
1. Cell proliferation in colorectal adenocarcinomas: comparison between Ki-67 immunostaining and bromodeoxyuridine uptake detected by immunohistochemistry and flow cytometry.
Le Pessot F; Michel P; Paresy M; Lemoine F; Hellot MF; Paillot B; Scotte M; Peillon C; Hemet J
Pathol Res Pract; 2001; 197(6):411-8. PubMed ID: 11432668
[TBL] [Abstract][Full Text] [Related]
2. Cellular proliferation in prostatic adenocarcinoma as assessed by bromodeoxyuridine uptake and Ki-67 and PCNA expression.
Cher ML; Chew K; Rosenau W; Carroll PR
Prostate; 1995 Feb; 26(2):87-93. PubMed ID: 7855002
[TBL] [Abstract][Full Text] [Related]
3. Relations of proliferative activities of gastric carcinoma cells to lymphatic involvement, venous invasion and prognosis.
Wu YF; Xu HM; Chen JQ
Chin Med J (Engl); 2004 Oct; 117(10):1530-5. PubMed ID: 15498378
[TBL] [Abstract][Full Text] [Related]
4. An evaluation of five different methods for estimating proliferation in human colorectal adenocarcinomas.
Wilson MS; Anderson E; Bell JC; Pearson JM; Haboubi NY; James RD; Schofield PF
Surg Oncol; 1994 Oct; 3(5):263-73. PubMed ID: 7889219
[TBL] [Abstract][Full Text] [Related]
5. Cell proliferation of human bladder tumors determined by BrdUrd and Ki-67 immunostaining.
Tsujihashi H; Nakanishi A; Matsuda H; Uejima S; Kurita T
J Urol; 1991 Apr; 145(4):846-9. PubMed ID: 2005717
[TBL] [Abstract][Full Text] [Related]
6. The prognostic value of proliferation indices: a study with in vivo bromodeoxyuridine and Ki-67.
Goodson WH; Moore DH; Ljung BM; Chew K; Mayall B; Smith HS; Waldman FM
Breast Cancer Res Treat; 2000 Jan; 59(2):113-23. PubMed ID: 10817346
[TBL] [Abstract][Full Text] [Related]
7. Immunostaining for proliferating cell nuclear antigen: its role in determination of proliferation in routinely processed human brain tumor specimens.
Khoshyomn S; Maier H; Morimura T; Kitz K; Budka H
Acta Neuropathol; 1993; 86(6):582-9. PubMed ID: 7906072
[TBL] [Abstract][Full Text] [Related]
8. Measurement of bromodeoxyuridine labeling index, Ki-67 score and Ag-NOR count in breast carcinomas. Comparison with DNA ploidy.
Sasaki K; Matsumura K; Murakami T; Tsuji T
Oncology; 1992; 49(2):147-53. PubMed ID: 1574251
[TBL] [Abstract][Full Text] [Related]
9. Ki-67 proliferating index and histological grade, type and stage of colorectal carcinoma.
Nabi U; Nagi AH; Sami W
J Ayub Med Coll Abbottabad; 2008; 20(4):44-8. PubMed ID: 19999202
[TBL] [Abstract][Full Text] [Related]
10. Direct comparison of bromodeoxyuridine and Ki-67 labelling indices in human tumours.
Wilson GD; Saunders MI; Dische S; Daley FM; Robinson BM; Martindale CA; Joiner B; Richman PI
Cell Prolif; 1996 Mar; 29(3):141-52. PubMed ID: 8652743
[TBL] [Abstract][Full Text] [Related]
11. Retrospective analysis of the prognostic significance of DNA ploidy patterns and S-phase fraction in gastric carcinoma.
Yonemura Y; Ooyama S; Sugiyama K; Kamata T; De Aretxabala X; Kimura H; Kosaka T; Yamaguchi A; Miwa K; Miyazaki I
Cancer Res; 1990 Feb; 50(3):509-14. PubMed ID: 2297693
[TBL] [Abstract][Full Text] [Related]
12. Age and bromodeoxyuridine labelling index as prognostic factors in high-grade gliomas treated with surgery and radiotherapy.
Gasinska A; Skolyszewski J; Glinski B; Niemiec J; Adamczyk A; Krzyszkowski T; Zabek M
Clin Oncol (R Coll Radiol); 2006 Aug; 18(6):459-65. PubMed ID: 16909969
[TBL] [Abstract][Full Text] [Related]
13. Comparison of proliferative activities and metastases between two subtypes classified at the deeply infiltrating sites of colorectal moderately differentiated adenocarcinomas.
Taniyama K; Sasaki N; Wada S; Sasaki M; Miyoshi N; Nakai H; Kodama S; Nakatsuka H; Tahara E
Pathol Int; 1996 Mar; 46(3):195-203. PubMed ID: 10846570
[TBL] [Abstract][Full Text] [Related]
14. Cell proliferation in prostatic adenocarcinoma: in vitro measurement by 5-bromodeoxyuridine incorporation and proliferating cell nuclear antigen expression.
Carroll PR; Waldman FM; Rosenau W; Cohen MB; Vapnek JM; Fong P; Narayan P; Mayall BH
J Urol; 1993 Feb; 149(2):403-7. PubMed ID: 8093910
[TBL] [Abstract][Full Text] [Related]
15. p53 expression in colorectal cancer: relation to tumor type, DNA ploidy pattern and short-term survival.
Lanza G; Maestri I; Dubini A; Gafa R; Santini A; Ferretti S; Cavazzini L
Am J Clin Pathol; 1996 May; 105(5):604-12. PubMed ID: 8623770
[TBL] [Abstract][Full Text] [Related]
16. Comparison of proliferating cell nuclear antigen versus the more standard measures of rectal mucosal proliferation rates in subjects with a history of colorectal cancer and normal age-matched controls.
Einspahr J; Alberts D; Xie T; Ritchie J; Earnest D; Hixson L; Powell M; Roe D; Grogan T
Cancer Epidemiol Biomarkers Prev; 1995 Jun; 4(4):359-66. PubMed ID: 7655331
[TBL] [Abstract][Full Text] [Related]
17. Ki-67 and proliferating cell nuclear antigen tumor proliferative indices in DNA diploid colorectal adenocarcinomas. Correlation with histopathologic characteristics and cell cycle analysis with two-color DNA flow cytometry.
Linden MD; Ma CK; Kubus J; Brown RD; Zarbo RJ
Am J Clin Pathol; 1993 Sep; 100(3):206-12. PubMed ID: 8104388
[TBL] [Abstract][Full Text] [Related]
18. Correlations of proliferation markers, p53 expression and histological findings in colorectal carcinoma.
Georgescu CV; Săftoiu A; Georgescu CC; Ciurea R; Ciurea T
J Gastrointestin Liver Dis; 2007 Jun; 16(2):133-9. PubMed ID: 17592558
[TBL] [Abstract][Full Text] [Related]
19. [Evaluation of the correlations of cell proliferation activity with lymphatic and vascular invasion and prognosis in gastric carcinoma].
Wu YF; Xu HM; Chen JQ
Zhonghua Zhong Liu Za Zhi; 2005 Aug; 27(8):492-5. PubMed ID: 16188150
[TBL] [Abstract][Full Text] [Related]
20. Relationships between nodal status and cell kinetics, DNA ploidy pattern and histopathology of the deeply infiltrating sites in colorectal adenocarcinoma.
Taniyama K; Suzuki H; Matsumoto M; Hakamada K; Toyama K; Tahara E
Acta Pathol Jpn; 1993 Oct; 43(10):590-6. PubMed ID: 8291447
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
